Pharmabotix AG
Pharmabotix AG is a Swiss engineering firm that designs GMP-compliant robotic automation systems — modular fill-finish platforms, sterile CGT solutions, and patented wireless isolator monitoring — for pharmaceutical, biotech, and medical-device manufacturers, sold direct via customized projects with lifecycle service.
- Company typePrivate
- Founded2020
- HeadquartersSeengen, Switzerland
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pharmabotix AG does
Pharmabotix AG is a privately held Swiss engineering company, headquartered in Seengen, Canton Aargau, that designs and delivers robotic automation systems for pharmaceutical, biotech, and medical-device manufacturers. The company's product portfolio centers on GMP-compliant modular platforms: the VialPro Line for autonomous fill-finish (FeedStar infeed up to 350 units/min, PackMate outfeed up to 350 units/min, LogChamp AGV/AMR material transport), the SettleShell wireless passive air sampler for gloveless isolators (protected by EU patent EP 4 577 635 B1), the Sally automated inoculum production system and Cryo-Filler for cell-and-gene-therapy applications, and compact assembly cells such as a Yaskawa HD7/HD8-based autoinjector line that won the ISPE Robotics of the Year Award. Underlying technology stacks integrate Stääubli, Fanuc, Denso, and Yaskawa robots with proprietary software, OPC UA / SRCI connectivity to MES/LIMS and WMS, and application-level computer vision for QC.
The business model combines upfront, project-based sales of custom automation systems with recurring lifecycle revenue from service contracts, preventive maintenance, system optimization, and prioritized support, plus professional services revenue from greenfield/brownfield consulting, feasibility studies, and process simulations. Go-to-market is direct enterprise field sales with no resellers, supported by a project inquiry form, a case-study-driven content presence, LinkedIn engagement, and participation in industry events such as ISPE and PDA. Customers are exclusively large pharmaceutical, biotech, CGT, and medical-device manufacturers, with named references including F. Hoffmann-La Roche AG and PSM GmbH; logos on the company website additionally include Genentech, Novartis, Merck, Bachem, Octum, Oechsler, Pixon, Zambon, Whitraven, and PPT Engineering. All systems are delivered with GAMP 5-aligned DQ/IQ/OQ documentation and ISO 9001:2015-certified quality processes, positioning Pharmabotix as a manufacturer-independent integrator serving the complex, compliance-driven end of pharmaceutical automation rather than standardized catalog equipment.
Pharmabotix AG firmographics
Firmographics- Name
- Pharmabotix AG
- Legal name
- Pharmabotix AG
- Website
- https://pharmabotix.ch
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Pharmabotix AG is a Swiss engineering firm that designs GMP-compliant robotic automation systems — modular fill-finish platforms, sterile CGT solutions, and patented wireless isolator monitoring — for pharmaceutical, biotech, and medical-device manufacturers, sold direct via customized projects with lifecycle service.
- Ownership category
- akta.pro rank
Pharmabotix AG industry classification
Industry- Product category
- Pharmaceutical Automation Equipment
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Compounding Pharmacy & Sterile Prep Workflow Systems (HLACAKAM)
- akta.pro secondary industries
- Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish) (HLAAABAG), Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations) (HLAGAIAD), Auto-Injectors (Disposable & Reusable) (HLAHAIAB)
Keywords
Where Pharmabotix AG is headquartered
LocationHeadquarters
- HQ city
- Seengen
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Pharmabotix AG business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Custom Automation Systems: Design, development, and delivery of customized robotic automation systems for pharmaceutical, biotech, and medical device manufacturing. Systems include assembly, filling, packaging, and inspection solutions. Revenue generated through upfront system sales with optional service contracts.
- Service Contracts & Lifecycle Services: Preventive maintenance, system optimization, system extensions, and technical training services. Service contracts with guaranteed response times and prioritized support. Annual recurring revenue through service agreements.
- Consulting & Engineering Studies: Greenfield and brownfield consulting, feasibility studies, process simulations, and workshop & engineering packages. Technical consulting services for pharmaceutical automation planning and validation.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Pharmabotix AG product offering
Product offeringCore offering
Pharmabotix AG designs, engineers, and delivers customized robotic automation systems for pharmaceutical, biotech, cell and gene therapy, and medical device manufacturers. Its offering spans the VialPro Line fill-finish platform, Sally inoculum production, Cryo-Filler, the patented SettleShell wireless air sampler, and autoinjector assembly systems, complemented by greenfield/brownfield consulting, feasibility studies, and lifecycle service contracts.
Product overview
Pharmabotix AG offers a modular portfolio of robotic automation solutions for pharmaceutical, biotech, and medical device manufacturing. The core offerings include the VialPro Line platform (comprising FeedStar infeed, PackMate outfeed, and LogChamp mobile robot modules) for autonomous fill-finish operations, the SettleShell wireless air sampling system (EU Patent EP 4 577 635 B1) for gloveless isolators, Sally for automated inoculum production in cell and gene therapy, Cryo-Filler for sterile cryo-vial filling, and autoinjector assembly systems. The company provides comprehensive services including consulting & feasibility studies, workshop & engineering packages, and lifecycle service support. All solutions follow GMP/GAMP 5 compliant development with documentation, validation (DQ/IQ/OQ), and audit-ready documentation. The modular architecture enables both standalone deployment and integrated line configurations with WMS, MES/LIMS, and AGV/AMR systems via OPC UA connectivity.
Differentiator
Problem solved
Functional benefit
Products and services
- VialPro Line
Quantifiable outcome
- FeedStar and PackMate operate at up to 350 units per minute for high-throughput vial and syringe handling
- +2 more outcomes
Companies that use Pharmabotix AG
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Pharmabotix AG technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability3 records
Feature5 records
Pharmabotix AG partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- YaskawacoreYaskawa provides MOTOMAN HD7 and HD8 sterile robots for pharmaceutical applications. Pharmabotix integrates these hygiene-designed robots (GMP-compliant up to Grade A, ISO 14644-1 cleanroom compatible, IP69 protection) into autoinjector assembly and other pharmaceutical automation systems. Partnership resulted in ISPE Robotics of the Year Award.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
Pharmabotix AG competitors and assessment
Company assessmentOthers
- Stäubli Robotics: Swiss-headquartered manufacturer of industrial and cleanroom-capable robots that Pharmabotix integrates into solutions (e.g., Stäubli Tx2-60L). Acts as both a technology supplier and partial competitor when delivering its own integrated automation cells.
- Yaskawa: Japanese industrial and hygienic robot manufacturer whose MOTOMAN HD7/HD8 sterile robots are core components of Pharmabotix's award-winning autoinjector line. Functions as a strategic technology partner but also as a competing systems integrator on larger pharma programs.
Broad incumbents
- IMA Group: Italian-headquartered leader in processing and packaging machinery for pharma and cosmetics, including aseptic fill-finish and lyophilization. Competes with Pharmabotix in GMP-validated sterile filling and integrated pharma line projects.
- Syntegon: Formerly Bosch Packaging Technology, Syntegon is one of the largest pharma processing and packaging machinery suppliers worldwide with deep GMP and validation know-how. Provides integrated lines and robotic solutions that overlap directly with VialPro-style fill-finish automation.
- GEA Group: Global engineering group with a substantial pharma processing equipment portfolio including aseptic liquid processing, isolation technology, and fill-finish. Overlaps with Pharmabotix on sterile liquid handling and isolator-integrated robotic automation.
- Körber Pharma: Global pharma-focused automation and equipment supplier offering integrated filling, packaging, inspection, and serialization lines. Competes head-to-head with Pharmabotix on GMP-compliant robotic automation for fill-finish, packaging, and sterile manufacturing at large pharma customers.
Direct peers
- Stevanato Group: Pharmaceutical glass packaging and integrated device/assembly specialist offering autoinjector assembly lines, visual inspection, and fill-finish platforms. Direct comparator on autoinjector assembly and pharma device manufacturing automation.
- SKAN AG: Swiss cleanroom and isolator specialist serving pharma and biotech with isolators, RABS, and sterile process equipment. Closest geographic and technical peer to Pharmabotix, particularly on sterile-process automation for ATMP and fill-finish applications.
- ATS Life Sciences: Division of ATS Corporation focused on automated assembly, fill-finish, and packaging systems for pharma and medical devices. Competes directly with Pharmabotix on customizable GMP-validated robotic automation for medical device assembly and pharma packaging.
- Bausch + Strobel: German manufacturer of aseptic filling and closing machines for the pharmaceutical industry with a long track record in sterile liquid processing. Direct comparator on aseptic fill-finish machinery and pharmaceutical packaging automation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Pharmabotix AG social profiles
Digital presencePharmabotix AG compliance and trust
Trust signalCompliance3 records
Pharmabotix AG financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmabotix AG leadership team
Management profileNumber of profiles
Profiles6 records
Pharmabotix AG funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmabotix AG M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmabotix AG
What does Pharmabotix AG do?
Pharmabotix AG designs, engineers, and delivers customized robotic automation systems for pharmaceutical, biotech, cell and gene therapy, and medical device manufacturers. Its offering spans the VialPro Line fill-finish platform, Sally inoculum production, Cryo-Filler, the patented SettleShell wireless air sampler, and autoinjector assembly systems, complemented by greenfield/brownfield consulting, feasibility studies, and lifecycle service contracts.
Is Pharmabotix AG a public or private company?
Pharmabotix AG is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Pharmabotix AG founded?
Pharmabotix AG was founded in 2020. It employs 1 to 10 people.
Where is Pharmabotix AG based?
Pharmabotix AG is headquartered in Seengen, Switzerland, in the Europe region.
How does Pharmabotix AG make money?
Three revenue lines are on record. Custom Automation Systems are the primary driver. The others are service Contracts & Lifecycle Services and consulting & Engineering Studies.
Who are Pharmabotix AG's main competitors?
Others on record are Stäubli Robotics and Yaskawa. Broad incumbents are IMA Group, Syntegon, GEA Group and Körber Pharma. Direct peers are Stevanato Group, SKAN AG, ATS Life Sciences and Bausch + Strobel.
Does Pharmabotix AG have an API?
No public API is recorded for Pharmabotix AG.
What industry is Pharmabotix AG in?
Pharmabotix AG's product category is Pharmaceutical Automation Equipment. Its primary akta.pro industry code is HLACAKAM, Compounding Pharmacy & Sterile Prep Workflow Systems, with a secondary code of HLAAABAG, Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish). Its NAICS code is 339112 and its SIC code is 3841.